Franklin-Silverman Liver Biopsy Needle 105mm — Pre-Menghini Standard

Franklin-Silverman 105mm Liver Biopsy Needle — Pre-Menghini Standard

The standard Franklin-Silverman 105mm liver-biopsy needle is the unmodified Vim-Silverman 1938 design that defined percutaneous liver biopsy in the pre-Menghini era. The procedure required 30-60 seconds of pleural-cavity transit during the cutting-biopsy action — the duration that produced the 5-10% pneumothorax complication rate that Menghini’s one-second technique reduced to under 1% in 1957.

The historical clinical context

Percutaneous liver biopsy was first reported by Lucatello in 1895 but did not become a routine procedure until the Vim-Silverman 1938 description provided a reproducible technique. The procedure transformed hepatology by enabling tissue diagnosis of chronic liver disease without surgical exploration. The complication rate of 5-10% (mostly pneumothorax and pleural-cavity bleeding) was acceptable in the pre-antibiotic era when the diagnostic alternative was surgical biopsy with substantially higher mortality.

The modern indication-spectrum

The 105mm Franklin-Silverman remains in use at centres where Menghini technique is unavailable, where cutting-biopsy architecture is specifically indicated, or where operator training favours the cutting-needle approach. Most modern liver biopsy is Menghini-technique or core-cutting-needle (e.g., 18G Achieve, Tru-Cut), but the Franklin-Silverman pattern persists in specific clinical-pathological indications.